Solasia Pharma K.K. (TYO:4597)
Japan · Delayed Price · Currency is JPY 26.00
+2.00 (8.33%)
May 29, 2026, 3:30 PM JST
Solasia Pharma K.K. Market Cap
Solasia Pharma K.K. has a market cap or net worth of 7.1 billion as of May 29, 2026. Its market cap has decreased by -1.36% in one year.
Market Cap
7.10B
Enterprise Value
5.62B
Revenue
410.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.00
Market Cap Chart
Since March 24, 2017, Solasia Pharma K.K.'s market cap has decreased from 22.86B to 7.10B, a decrease of -68.95%. That is a compound annual growth rate of -11.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 7.10B | -6.15% |
| Dec 30, 2025 | 7.56B | -3.61% |
| Dec 30, 2024 | 7.85B | 3.52% |
| Dec 29, 2023 | 7.58B | -7.91% |
| Dec 30, 2022 | 8.23B | -42.39% |
| Dec 30, 2021 | 14.29B | 0.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharma Foods International | 18.79B |
| Fuso Pharmaceutical Industries,Ltd. | 17.40B |
| Taiko Pharmaceutical | 12.86B |
| Wakamoto Pharmaceutical | 9.71B |
| Morishita Jintan | 8.85B |
| WDB coco | 6.20B |
| Cyfuse Biomedical K.K. | 5.88B |
| Nippon Chemiphar | 5.81B |